Ingevity's PFAS filtration win turns a promise into a contract — as the portfolio overhaul enters its final mile
Q2 2026: margins expand 600bps to 36.6%, APT sale in "advanced stage," and a first municipal water-treatment deal validates a new growth vector while the tariff-refund wave passes the company by
NGVT · Earnings Call · 2026-07-30
The final mile of the portfolio overhaul
Ingevity's Q2 2026 report is the clearest confirmation yet that its two-year transformation — exiting Industrial Specialties and, in April, Road Markings — is compounding. Ex-divestiture sales grew 5% across all three segments, adjusted EBITDA rose 14% to $115 million, and EBITDA margins expanded more than 600 basis points to 36.6%. The mechanism, per CFO Phillip Platt, is a mix story as much as a cost story: “really what you are seeing a lot in the margin uplift is really the mix in Performance Materials and our ability to run the plants at really high throughputs.” — Phillip J. Platt, Chief Financial Officer · 2026-07-30 Stranded-cost elimination ($10M of a planned $15M) is on pace, and net leverage hit 2.5x — the top of the target band set at last December's strategic portfolio update.The last major asset, Advanced Polymer Technologies, is now in an "advanced stage" of its sale process, a step forward from the prior cadence of “we continue to be confident that we'll announce something before the end of the year” — David Li, Chief Executive Officer · 2026-05-07 (May 2026). APT itself swung to an $11M quarter (from $2M a year ago), though part of that benefit — competitor supply disruptions from the Middle East conflict — is already normalizing, leaving the business to stand on its own fundamentals.Hybrids and the 54%-margin machine
Performance Materials remains the crown jewel, printing 53.6% EBITDA margins on the strength of the structural shift to hybrid vehicles, which consume Ingevity's most advanced carbon. The management team struck a confident tone on durability: “It seems like the hybrids, especially in North America, are really hitting a sweet spot for the consumer. Obviously, hybrids also require our most advanced carbon solutions and also produce a higher-value product mix.” — David H. Li, Chief Executive Officer · 2026-07-30 This isn't new — the prior call flagged the same tailwind — but the consistency is the signal: the North American consumer has now moderated pure-EV adoption two quarters running, a durable positive for Hybrid vehicles.The second half will take a step back, however. Planned maintenance outages at two PM facilities and softer North American auto production are baked into the raised guidance (adjusted EBITDA $380–400M; EPS $5.00–5.45). Management frames this as plant utilization normalizing after an exceptionally efficient Q2 — a timing shift, not a demand break.A first contract makes filtration real
The genuinely new data point this quarter is a revenue line, not just a narrative: “During the quarter, we secured our first municipal water treatment contract for PFAS filtration.” — David H. Li, Chief Executive Officer · 2026-07-30 Crucially, this was not a price win. David Li was explicit in Q&A:That's a meaningful progression from the "discovery process" language of earlier calls — last February Li told analysts filtration was still exploratory: “we're definitely in the discovery process, but we're encouraged, and we've seen some good support from some of those end markets.” — David Li, Chief Executive Officer · 2026-02-26 The municipal contract converts that exploration into a referenceable proof point in the attractive water treatment market.For a business whose activated carbon volumes are otherwise tied to auto production, PFAS filtration is a diversifier with regulatory tailwind — and it slots alongside Evotherm warm-mix (up 8% this quarter) and energy storage as organic growth vectors that require minimal capital.We were not the low bidder for that opportunity. We were chosen because of the differentiation of our technology.